168 related articles for article (PubMed ID: 24950702)
1. COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.
Pomianowska E; Schjølberg AR; Clausen OP; Gladhaug IP
BMC Cancer; 2014 Jun; 14():458. PubMed ID: 24950702
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.
Pomianowska E; Westgaard A; Mathisen Ø; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Jan; 20(1):233-41. PubMed ID: 22893118
[TBL] [Abstract][Full Text] [Related]
3. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
4. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract][Full Text] [Related]
5. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer.
Pomianowska E; Grzyb K; Westgaard A; Clausen OP; Gladhaug IP
Eur J Surg Oncol; 2012 Nov; 38(11):1043-50. PubMed ID: 22883964
[TBL] [Abstract][Full Text] [Related]
6. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR
Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201
[TBL] [Abstract][Full Text] [Related]
8. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors in pancreatic and ampullary cancer.
Lemke J; Schäfer D; Sander S; Henne-Bruns D; Kornmann M
Anticancer Res; 2014 Jun; 34(6):3011-20. PubMed ID: 24922667
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival.
Lei S; Appert HE; Nakata B; Domenico DR; Kim K; Howard JM
Int J Pancreatol; 1995 Feb; 17(1):15-21. PubMed ID: 8568330
[TBL] [Abstract][Full Text] [Related]
11. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.
Matsubayashi H; Infante JR; Winter J; Klein AP; Schulick R; Hruban R; Visvanathan K; Goggins M
Cancer Biol Ther; 2007 Oct; 6(10):1569-75. PubMed ID: 18000398
[TBL] [Abstract][Full Text] [Related]
12. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
13. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
[TBL] [Abstract][Full Text] [Related]
14. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
15. Does lymph node ratio impact survival in resected periampullary malignancies?
Hurtuk MG; Hughes C; Shoup M; Aranha GV
Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
[TBL] [Abstract][Full Text] [Related]
16. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
[TBL] [Abstract][Full Text] [Related]
17. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
19. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology.
Morris-Stiff G; Alabraba E; Tan YM; Shapey I; Bhati C; Tanniere P; Mayer D; Buckels J; Bramhall S; Mirza DF
Eur J Surg Oncol; 2009 Jul; 35(7):746-50. PubMed ID: 19167859
[TBL] [Abstract][Full Text] [Related]
20. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
